Healthcare Services

Osteoarthritis Market Growth Expected to Reach $11.91 Billion by 2030 with 9.9% CAGR

April 3, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Osteoarthritis Market From 2026 To 2030?

The osteoarthritis market has experienced significant expansion in recent years. It is projected to increase from $7.49 billion in 2025 to $8.16 billion in 2026, with a compound annual growth rate (CAGR) of 8.9%. The market’s past growth can be attributed to factors such as the rising global incidence of osteoarthritis, the early limited availability of advanced joint therapies, an expanding aging population suffering from joint degeneration, the initial use of conventional medications and surgeries, and increasing awareness regarding joint health and pain management.

The osteoarthritis market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $11.92 billion, demonstrating a compound annual growth rate (CAGR) of 9.9%. This projected growth is driven by several factors, including the increasing embrace of minimally invasive and robotic-assisted surgical procedures, the expanding application of biologics and DMOADs, improvements in healthcare infrastructure dedicated to joint care, the wider implementation of digital diagnostics and AI-powered monitoring, and heightened patient understanding of lifestyle and weight management initiatives. Key trends shaping the forecast period involve a greater acceptance of minimally invasive joint replacement surgeries, the broadened utilization of biologic therapies and hyaluronic acid injections, the evolving integration of digital imaging with AI-based diagnostics, a heightened emphasis on individualized osteoarthritis management strategies, and increased funding for physical therapy and rehabilitation efforts.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

What Key Drivers Are Influencing The Growth Of The Osteoarthritis Market?

A rise in obesity-related disorders is projected to propel the expansion of the osteoarthritis market in the future. These problems encompass various health conditions stemming from excessive body fat. This condition often results from a caloric surplus, where calorie intake exceeds expenditure through physical activity and exercise, coupled with significant consumption of processed or fast food, and excessive alcohol intake. Obesity contributes to osteoarthritis development by placing stress on joints, triggering inflammation, and altering hormonal balance, thereby intensifying the burden on joints. As an illustration, data from September 2024, reported by the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, indicated an increase in states where adult obesity prevalence reached 35% or greater, moving from 22 states in 2022 to 23 states in 2023. Consequently, the growing incidence of obesity-related disorders is fostering the expansion of the osteoarthritis market.

Which Segments Are Included In The Analysis Of The Osteoarthritis Market?

The osteoarthritis market covered in this report is segmented –

1) By Treatment: Medication, Surgery, Therapy

2) By Diagnosis: Imaging, Joint Fluid Analysis

3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route

4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis

5) By End-User: Hospitals, Medical Institutes

Subsegments:

1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)

2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion

3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices

How Are Trends Impacting The Osteoarthritis Market?

Major companies within the osteoarthritis market are increasingly adopting strategic partnership approaches to foster technology integration and expand their market reach. Such partnerships typically signify a collaborative relationship between two or more organizations, where they pool resources, expertise, and efforts to achieve shared goals or objectives. As an illustration, in July 2024, LG Chem, a pharmaceutical company based in South Korea, entered the Chinese market through a collaboration with Yifan Pharmaceutical Co., Ltd., a China-based pharmaceutical research and production entity. This partnership aimed to launch Synovian injection for osteoarthritis, designed to deliver therapeutic effects similar to traditional multi-injection formulations but with the convenience of just one administration. Synovian’s distinct attributes include its high molecular weight (10 million Dalton) hyaluronic acid, which improves viscoelasticity and joint function, and its proven ability to significantly reduce knee pain, substantiated by clinical phase 3 trial results. This innovation positions Synovian as an effective choice for patients seeking convenient relief from osteoarthritis symptoms.

Which Key Industry Participants Are Active In The Osteoarthritis Market?

Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics plc, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

Read the full osteoarthritis market report here:

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Osteoarthritis Market?

North America was the largest region in the osteoarthritis market in 2025. The regions covered in the osteoarthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Osteoarthritis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13022&type=smp

Browse Through More Reports Similar to the Global Osteoarthritis Market 2026, By The Business Research Company

Soft Tissue Repair Global Market Report

https://www.thebusinessresearchcompany.com/report/soft-tissue-repair-global-market-report

Orthopedic Regenerative Surgical Products Global Market Report

https://www.thebusinessresearchcompany.com/report/orthopedic-regenerative-surgical-products-global-market-report

Cartilage Repair Global Market Report

https://www.thebusinessresearchcompany.com/report/cartilage-repair-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795